Tarsus Pharmaceuticals, Inc.
TARS
$58.85
$2.243.96%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.79% | 36.64% | 28.11% | 28.38% | 81.55% |
| Total Receivables | 95.32% | 104.56% | 171.31% | 375.73% | 12,436.99% |
| Inventory | 76.45% | -32.98% | -15.67% | 18,873.33% | -- |
| Prepaid Expenses | 388.50% | -11.82% | 86.20% | 16.78% | 19.39% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 30.85% | 41.10% | 39.27% | 37.74% | 97.62% |
|
|
|||||
| Total Current Assets | 30.85% | 41.10% | 39.27% | 37.74% | 97.62% |
| Net Property, Plant & Equipment | -18.98% | -8.36% | -14.40% | 15.72% | 14.46% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 113.96% | 114.65% | 115.31% | 115.96% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 86.68% | 333.64% | 372.77% | 189.92% | 151.79% |
| Total Assets | 31.35% | 43.37% | 42.00% | 40.24% | 99.47% |
|
|
|||||
| Total Accounts Payable | 5.34% | 48.28% | 56.08% | 158.28% | 226.15% |
| Total Accrued Expenses | 96.71% | 115.75% | 37.73% | 81.44% | 38.14% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -47.60% | -34.36% | 52.76% | 49.17% | 40.37% |
| Total Finance Division Other Current Liabilities | 185.53% | 166.71% | 580.54% | 500.79% | -- |
| Total Other Current Liabilities | 185.53% | 166.71% | 580.54% | 500.79% | -- |
| Total Current Liabilities | 75.01% | 102.94% | 118.25% | 183.32% | 249.28% |
|
|
|||||
| Total Current Liabilities | 75.01% | 102.94% | 118.25% | 183.32% | 249.28% |
| Long-Term Debt | 0.77% | 140.48% | 140.94% | 141.38% | 190.88% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -25.61% | -20.17% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 30.32% | 113.71% | 122.56% | 153.93% | 202.44% |
|
|
|||||
| Common Stock & APIC | 30.41% | 30.96% | 32.36% | 37.90% | 81.82% |
| Retained Earnings | -29.33% | -37.43% | -47.23% | -66.26% | -91.73% |
| Treasury Stock & Other | 122.16% | 234.92% | 9,050.00% | 4,425.00% | -665.22% |
| Total Common Equity | 31.86% | 24.43% | 13.98% | 11.15% | 70.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 31.86% | 24.43% | 13.98% | 11.15% | 70.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 31.86% | 24.43% | 13.98% | 11.15% | 70.75% |
|
|
|||||